New cancer pill ZX-8177 enters human testing for advanced tumors
Disease control
Recruiting now
This early-stage trial tests an experimental tablet called ZX-8177 in 80 Chinese patients with advanced solid tumors that have not responded to standard treatments. The study aims to find the safest dose and check for any signs that the drug can shrink tumors. It is a first step …
Phase: PHASE1 • Sponsor: Nanjing Zenshine Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC